Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

3.300

-0.220 (-6.25%)

At close: Feb 21, 2025, 4:00 PM

3.340

+0.040 (1.21%)

After-hours: Feb 21, 2025, 4:23 PM EST

Amylyx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb '25 Feb 21, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	225	994	2,448	-	-	-
Market Cap Growth	-82.12%	-59.40%	-	-	-	-
Enterprise Value	-7	644	2,292	-	-	-
Last Close Price	3.30	14.72	36.95	-	-	-
PE Ratio	-	20.17	-	-	-	-
Forward PE	-	16.68	-	-	-	-
PS Ratio	1.14	2.61	110.13	-	-	-
PB Ratio	1.15	2.29	7.19	-	-	-
P/TBV Ratio	1.12	2.29	7.19	-	-	-
P/FCF Ratio	-	93.08	-	-	-	-
P/OCF Ratio	-	83.38	-	-	-	-
EV/Sales Ratio	-	1.69	103.12	-	-	-
EV/EBITDA Ratio	-	16.13	-	-	-	-
EV/EBIT Ratio	-	16.59	-	-	-	-
EV/FCF Ratio	-	60.27	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	-	0.27	-0.84
Debt / EBITDA Ratio	-	0.10	-	-	-	-
Debt / FCF Ratio	-	0.40	-	-	-	-
Asset Turnover	0.55	0.84	0.09	0.00	0.08	-
Inventory Turnover	-	6.39	-	-	-	-
Quick Ratio	4.38	5.02	7.78	5.53	1.76	0.68
Current Ratio	4.55	5.66	8.20	6.03	1.86	0.71
Return on Equity (ROE)	-84.43%	12.73%	-92.53%	-188.05%	-	-
Return on Assets (ROA)	-43.44%	5.34%	-50.63%	-86.34%	-281.44%	-
Return on Capital (ROIC)	-50.10%	6.18%	-57.85%	-108.86%	-1215.56%	-
Return on Capital Employed (ROCE)	-	8.91%	-	-	-	-
Earnings Yield	-115.49%	4.96%	-8.10%	-	-	-
FCF Yield	-58.66%	1.07%	-7.45%	-	-	-
Buyback Yield / Dilution	1.59%	-19.65%	-788.13%	-8.37%	-3.20%	-
Total Shareholder Return	1.59%	-19.65%	-788.13%	-8.37%	-3.20%	-

Source: S&P Capital IQ. Standard template. Financial Sources.